BackImmage Biotherapeutics Overview

Immage Biotherapeutics Common Stock

Immage Biotherapeutics's common stock is $150K.

Get informed when a big investor buys or sells

+ Follow
Common Stock
$151745.00
↑ 3.41% YoYΔ $5000.00 vs prior year quarter

Peer trimmed avg / median

Loading

Immage Biotherapeutics Common Stock History

Loading

Immage Biotherapeutics vs. peers: Common Stock Comparison

Loading

Immage Biotherapeutics Common Stock Growth (YoY per quarter)

Latest change versus the prior comparable period (same company). Positive growth indicates new issuance/dilution; negative growth indicates reductions/buybacks.

Loading

Immage Biotherapeutics (IMMG) FAQ

As of the most recent data (February 2017), IMMG shows a common stock of $150K. That compares with $150K in the prior-year period — up 3.4% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, IMMG's common stock is now $150K (was $150K) — a 3.4% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Immage Biotherapeutics is outperforming or lagging.

Tracking IMMG's common stock over time shows whether Immage Biotherapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $150K That compares with $150K in the prior-year period — up 3.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this common stock page, Stockcircle has Immage Biotherapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect common stock (currently $150K) with ownership activity and broader fundamentals.

Questions & Answers